Literature DB >> 9463487

Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.

R M Krause1, B Buisson, S Bertrand, P J Corringer, J L Galzi, J P Changeux, D Bertrand.   

Abstract

We report that preapplication of ivermectin, in the micromolar range, strongly enhances the subsequent acetylcholine-evoked current of the neuronal chick or human alpha7 nicotinic acetylcholine receptors reconstituted in Xenopus laevis oocytes and K-28 cells. This potentiation does not result from nonspecific Cl- currents. The concomitant increase in apparent affinity and cooperativity of the dose-response curve suggest that ivermectin acts as a positive allosteric effector. This interpretation is supported by the observation of an increase in efficiency of a partial agonist associated with the potentiation and by the differential effect of ivermectin on mutants within the M2 channel domain. Ivermectin effects reveal a novel allosteric site for pharmacological agents on neuronal alpha7 nicotinic acetylcholine receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9463487     DOI: 10.1124/mol.53.2.283

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  104 in total

1.  Allosteric control of gating and kinetics at P2X(4) receptor channels.

Authors:  B S Khakh; W R Proctor; T V Dunwiddie; C Labarca; H A Lester
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

2.  Allosteric modulators affect the efficacy of partial agonists for recombinant GABA(A) receptors.

Authors:  G Maksay; S A Thompson; K A Wafford
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A.

Authors:  Jonathan G Bilmen; Laura L Wootton; Francesco Michelangeli
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

Review 4.  Allosteric modulation of ATP-gated P2X receptor channels.

Authors:  Claudio Coddou; Stanko S Stojilkovic; J Pablo Huidobro-Toro
Journal:  Rev Neurosci       Date:  2011-03-16       Impact factor: 4.353

Review 5.  Biased signalling and allosteric machines: new vistas and challenges for drug discovery.

Authors:  Terry P Kenakin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

6.  Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator.

Authors:  Toby Collins; Neil S Millar
Journal:  Mol Pharmacol       Date:  2010-05-12       Impact factor: 4.436

Review 7.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

8.  Altered hippocampal synaptic potentiation in P2X4 knock-out mice.

Authors:  Joan A Sim; Séverine Chaumont; Jihoon Jo; Lauriane Ulmann; Mark T Young; Kwangwook Cho; Gary Buell; R Alan North; Francois Rassendren
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

Review 9.  Ion channels: molecular targets of neuroactive insecticides.

Authors:  Valérie Raymond-Delpech; Kazuhiko Matsuda; Benedict M Sattelle; James J Rauh; David B Sattelle
Journal:  Invert Neurosci       Date:  2005-10-24

Review 10.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.